<?xml version="1.0" encoding="UTF-8"?>
<ref id="ppat.1007395.ref016">
 <label>16</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Deal</surname>
   <given-names>CE</given-names>
  </name>, 
  <name>
   <surname>Balazs</surname>
   <given-names>AB</given-names>
  </name>. 
  <article-title>Engineering humoral immunity as prophylaxis or therapy</article-title>. 
  <source>Curr Opin Immunol. Elsevier Ltd</source>; 
  <year>2015</year>;
  <volume>35</volume>: 
  <fpage>113</fpage>â€“
  <lpage>122</lpage>. 
  <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.coi.2015.06.014" xmlns:xlink="http://www.w3.org/1999/xlink">10.1016/j.coi.2015.06.014</ext-link>
  <?supplied-pmid 26183209?>
  <pub-id pub-id-type="pmid">26183209</pub-id>
 </mixed-citation>
</ref>
